The liver is frequently exposed to insults, including toxic chemicals and alcohol, viral infection or metabolic overload. Although it can fully regenerate after acute injury, chronic liver damage causes liver fibrosis and cirrhosis, which can result in complete liver failure. In this study, we demonstrate that the NF-E2-related factor 2 (Nrf2) transcription factor protects the liver from acute and chronic toxin-mediated damage. Repair of the liver injury that occurs after a single treatment with the hepatotoxin carbon tetrachloride (CCl 4 ) was severely delayed in Nrf2-deficient mice. The defect in repair was accompanied by an enhanced and prolonged inflammatory and profibrotic response. After long-term CCl 4 treatment, liver fibrosis was strongly aggravated in the Nrf2 knockout mice and inflammation was enhanced. We demonstrate that these abnormalities are at least in part due to the reduced expression of known and novel Nrf2 target genes in hepatocytes, which encode enzymes involved in the detoxification of CCl 4 and its metabolites. These results suggest that activation of Nrf2 may be a novel strategy to prevent or ameliorate toxin-induced liver injury and fibrosis.
In contrast to other organs, the liver has the unique capability to regenerate after injury. Loss of functional liver tissue by surgery, necrosis induced by toxins, autoimmune disorders, cholestatic or metabolic diseases or viral infections, starts a well-orchestrated process that aims to restore the lost tissue, resulting in full regeneration. However, sustained presence of the damaging insult prolongs the wound healing response, resulting in liver fibrosis and cirrhosis or acute liver failure. 1, 2 Of particular importance for impaired regeneration is permanent oxidative stress caused by toxins, such as ethanol or haloalkanes, which results in excessive damage of hepatocytes through lipid peroxidation and alkylation of proteins, nucleic acids and lipids. 3, 4 Necrotic and apoptotic death of hepatocytes leads to activation of hepatic stellate cells (HSCs). The latter are responsible for enhanced deposition of fibrillar collagen, regular ECM degradation by proteases, and expression of a wide range of cytokines such as transforming growth factor-b (TGF-b), which in turn induce liver fibrosis (reviewed by Friedman 2, 5 ). Oxidative stress is generated in the liver by reactive oxygen species (ROS) produced by activated inflammatory cells via NAD(P)H oxidases, metabolic intermediates of xenobiotics, mitochondrial leakage and by the induction of the cytochrome P450 2 oxidase family (Cyp2). 4, 6 To avoid damage by ROS or promotion of fibrosis, the liver has a sophisticated antioxidant defense system. A central role in the defense against oxidative stress has been attributed to NF-E2-related factor 2 (Nrf2). Expression of many antioxidant proteins and detoxifying enzymes such as glutathione S-transferases (GSTs), NAD(P)H quinone oxidoreductase 1 (NQO1) and glutamate-cysteine ligase catalytic subunit (GCLC) and modulatory subunit are controlled by this transcription factor. 7 The family of Nrf transcription factors comprises, besides Nrf2, the closely related proteins Nrf1 and Nrf3, as well as p45 NF-E2, Bach1 and Bach2. 8 They activate expression of their target genes by a cis-acting enhancer element, called antioxidant response element. 9 Recently, our laboratory identified a crucial role of Nrf2 in liver regeneration after partial hepatectomy. 10 Enhanced oxidative stress caused transient insulin/insulin-like growth factor resistance in Nrf2-deficient hepatocytes, thereby inhibiting efficient liver regeneration. Furthermore, others showed a crucial role of Nrf2 in the protection of hepatocytes from acetaminophen, 11, 12 ethanol 13 and bile acid toxicity.
14 Recent reports suggested a role of Nrf2 in the activation of HSC, 15 and the activity of Nrf2 was dramatically induced by cholestasis. 16 To further investigate the function of Nrf2 in liver injury and repair and to study its role in liver fibrosis, we subjected Nrf2 knockout and wild-type mice to acute and chronic CCl 4 -induced liver damage. 17 Our results revealed a crucial role of Nrf2 in the protection from acute and chronic liver injury. Most importantly, Nrf2 was identified as an important player in the prevention of fibrosis.
MATERIALS AND METHODS Animals
Mice with targeted disruption of the nrf2 gene were described previously. 18 Animals were housed and fed according to federal guidelines. All experiments with mice were approved by the local veterinary authorities of Zurich, Switzerland.
CCl 4 -Induced Acute Liver Injury
Female Nrf2 knockout and control mice (8-to 10-week-old) were injected i.p. with a single dose of CCl 4 (0.4 mg/g body weight (BW) in mineral oil; Sigma, Munich, Germany). At different time points after CCl 4 injection, they were killed by CO 2 inhalation, and livers were harvested. Livers from untreated and mineral oil-treated animals served as controls.
CCl 4 -Induced Liver Fibrosis
Six-week-old female mice (Nrf2 knockout and wild-type controls) were treated with 15 doses of CCl 4 (0.2 mg/g BW in mineral oil; Sigma) over a time period of 45 days. At 72 h after the last injection, mice were killed as described above, and livers were harvested. Livers from mice treated with mineral oil only served as control.
Histology, Histomorphometry and Grading
Livers were fixed overnight in 4% paraformaldehyde (PFA) in PBS, embedded in paraffin, and sectioned. Sections (3.5 mm) were stained with hematoxylin/eosin (HE), Sirius Red (Sigma) or using the Masson trichrome procedure. HE stained sections were photographed (3-5 pictures per animal), and the necrotic area was determined morphometrically.
Hepatic inflammation after long-term CCl 4 treatment was graded numerically according to a score proposed by Thompson et al. 19 The four different scores are as follows: Score 1: Scanty cells present at junction of necrotic zone; Score 2: Cells regularly present; Score 3: Predominantly neutrophils present; Score 4: Predominantly mononuclear cells present.
Serology
Blood was taken by heart punctuation of mice that had developed CCl 4 -induced fibrosis or at different time points after a single CCl 4 treatment. Following blood coagulation, serum was collected after centrifugation. Serology was determined using standard procedures.
Labeling of Proliferating Cells with 5-bromo-2
0 -deoxyuridine At 2 h before killing, mice were injected i.p. with 250 mg/kg 5-bromo-2 0 -deoxyuridine (BrdU; Sigma). Livers were fixed in 95% ethanol/1% acetic acid, embedded in paraffin and sectioned (3.5 mm). BrdU-positive cells were subsequently detected by immunohistochemistry using a peroxidasecoupled mouse monoclonal antibody directed against BrdU (Roche, Rotkreuz, Switzerland).
Terminal dUTP Nick-End Labeling Assay
Terminal dUTP nick-end labeling (TUNEL) assays were performed according to the manufacturer's manual (Roche) using 3.5 mm paraffin sections of tissue that had been fixed in 4% PFA in PBS.
Immunofluorescence and Immunohistochemistry Cryosections (7 mm) were fixed in methanol. Alternatively, acidic ethanol-fixed paraffin sections (3.5 mm) were used. Sections were incubated overnight at 41C with antibodies to ER-MP23 (Abcam, Cambridge, UK), fibronectin (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and Ly6G (BD Pharmingen, Allschwil, Switzerland), diluted in 3% bovine serum albumin/PBS/0.02% Tween 20 (v/v). After three washes in PBS/0.1% Tween 20, sections were incubated with fluorophore-coupled secondary antibodies (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) and nuclei were counterstained with Hoechst (Molecular Probes, Basel, Switzerland). Alternatively, immunocomplexes were detected using biotinylated secondary antibodies (Jackson ImmunoResearch). Signals were visualized using the ABC staining kit (Vector Laboratories, Burlingame, CA, USA).
RNA Isolation and RNase Protection Assay
Isolation of total RNA and RNase protection assay (RPA) were performed as described. 20 RPAs were performed in duplicate using RNAs from different experiments. The following templates were used in this study: cDNAs encoding murine GCLC, GST-Ya, GST-p, NQO1, 10 collagen Ia1 (Coll-Ia1), glyceraldehyde 3-phosphate dehydrogenase (GAPDH), 21 and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) 22 and nucleotides 1091-1342 of the TGF-b1 cDNA (NM_011577.1).
Semiquantitative RT-PCR and Real-Time RT-PCR RNA was isolated as described above and cDNA was generated using the iScript RT kit (Bio-Rad, Rheinach, Switzerland) according to the manufacturer's instructions. Primers for carboxyl esterase (Ces) 1 (NM_021456 0 -CCTCCAATGGATCCT CGTTA) was used for normalization.
Statistical Analysis
Statistical analysis was performed using the Prism4 statistical program. P-values are two-tailed and were calculated using the Mann-Whitney U-test. P-values to compare variance were calculated using the F-test.
RESULTS

Nrf2 Protects from Acute CCl 4 -Induced Liver Damage
We recently identified a crucial role of Nrf2 in liver regeneration after partial hepatectomy. 10 This regeneration model induces compensatory hyperproliferation of the hepatocytes in the remaining liver with only minimal necrosis. 24 In contrast, liver damage caused by hepatotoxic chemicals induces compensatory hepatic hyperplasia after severe liver necrosis due to direct damage of hepatocytes and subsequent inflammation. 25 To determine if Nrf2 is also protective under these more harmful conditions, we utilized CCl 4 as a model hepatotoxic agent that allowed the evaluation of both necrosis and subsequent inflammation 26 and fibrosis. 17 Furthermore, acute CCl 4 treatment had recently been shown to induce nuclear translocation of Nrf2 and activation of the Nrf2 target gene heme oxygenase-1. 27 However, the functional role of Nrf2 in this injury model was previously unknown.
Nrf2 knockout mice and wild-type controls were injected i.p. with a single dose of CCl 4 . This treatment causes severe hepatocyte necrosis 26 ( Figure 1a ). Histopathological analysis of liver sections revealed similar hepatocellular damage 24 h after CCl 4 injection in mice of both genotypes ( Figure 1a , first panel). However, after 48 h, the extent of necrosis in the central zones of the liver appeared stronger in Nrf2 knockout mice ( Figure 1a , second panel). Morphometric analysis of the necrotic area confirmed these findings. No significant difference was observed between mice of both genotypes 24 h after CCl 4 injection, suggesting that the lack of Nrf2 does not aggravate the initial injury (Figure 1b) . At 36 h after injury, the necrotic area was already reduced in wild-type mice but not in Nrf2 knockout mice, although the difference between mice of both genotypes was not statistically significant. However, while the necrotic area was further reduced in the wild-type mice 48 h after injury, no reduction or even a slight increase in the necrotic area was observed in Nrf2 knockout mice at this time point. Thus, only 18% of the liver area was affected in wild-type mice vs 35% in Nrf2-deficient mice (Figure 1a and b) . Repair of the damage subsequently started in the Nrf2 knockout mice, and 72 h after CCl 4 injection the necrotic area was reduced to a similar extent in wild-type and knockout mice. At 5 days after CCl 4 injection, mice of both genotypes had almost completely recovered, and no significant difference in the necrotic area was observed between Nrf2 knockout and wild-type mice ( Figure 1a , third panel and b). These findings suggest that repair of the damage is delayed in Nrf2 knockout mice, and this was particularly obvious when the percentage of repaired necrotic area was statistically analyzed in mice of both genotypes ( Figure 1b , lower panel). Furthermore, the time course of cell proliferation in the injured liver strengthens this hypothesis (see below).
Mice of both genotypes that were injected with the vehicle (mineral oil) alone did not display any necrotic areas (data not shown).
Serum aminotransferase levels paralleled the histopathological findings (Figure 1c) . At 24 h after CCl 4 injection alanine aminotransferase (ALT) levels were similar in wildtype and Nrf2-deficient mice. However, while 36 h after injury ALT levels dropped in wild-type mice, they remained elevated in Nrf2-deficient mice. At 48 h after the insult, ALT levels had decreased in both groups; however, serum levels were significantly higher in Nrf2-deficient mice. At 5 days after CCl 4 injection ALT serum levels had returned to the levels seen before liver injury in mice of both genotypes. Analysis of aspartate aminotransferase serum activities revealed a similar pattern (data not shown). Together, these results demonstrate that Nrf2 knockout mice can repair the initial defect, albeit with a significant delay.
In addition to necrosis, hepatocytes may undergo apoptosis in response to CCl 4 treatment. TUNEL staining revealed a similar number of apoptotic cells in mice of both genotypes 24 and 48 h after injury (Figure 1d ). Injection of mineral oil alone did not induce apoptosis in wild-type or knockout mice (data not shown). These results demonstrate that Nrf2 did not protect from apoptotic cell death in this injury model.
Delayed Onset of Hepatocyte Proliferation in Nrf2 Knockout Mice After Acute CCl 4 -Mediated Liver Damage
We next determined if the more severe liver damage seen in Nrf2-deficient mice 48 h after injury results from a delayed onset of hepatocyte proliferation. To address this question, we analyzed liver cell proliferation by incorporation of the nucleotide analogon BrdU. Nrf2 in liver fibrosis W Xu et al cells was (nonsignificantly) higher in the knockout mice compared with wild-type mice. At 120 h after CCl 4 injection (day 5), proliferation had stopped in mice of both genotypes. Although the differences in BrdU positivity at any given time point were not statistically different due to high variability in the number of BrdU-positive cells (in particular in wild-type mice), the data at 36 h strongly suggest an earlier onset of proliferation in the presence of Nrf2. Indeed, analysis of variance of the dataset supports this hypothesis, as the overall time courses for BrdU positivity in wild-type vs knockout mice were significantly different (P ¼ 0.033). In mice treated with mineral oil alone, numbers of BrdU-positive cells were similarly low as in untreated mice at all time points (data not shown). Taken together, these results strongly suggest that the lack of Nrf2 does not aggravate the initial injury but delays the onset of liver repair after a toxic insult.
Enhanced Expression of Proinflammatory Cytokines and Persistence of Neutrophils After Acute CCl 4 -Induced Liver Damage
We next determined if the lack of Nrf2 and thus the reduced detoxification of CCl 4 and its metabolites affect the inflammatory response after acute CCl 4 -mediated liver injury. For this purpose, liver tissue was analyzed at different time points after CCl 4 injection for the presence of inflammatory cells. Immunostaining with an antibody against the neutrophil marker Ly6G revealed a strong neutrophil infiltrate in mice of both genotypes at day 1 after injury, reflecting the severe necrosis in the treated liver (Figure 3b) . One day later, the number of neutrophils was strongly reduced. No difference in the number of neutrophils was seen between wild-type and knockout mice at these early time points. However, 5 days after CCl 4 injection, the number of neutrophils had further decreased in the wild-type mice, whereas it remained elevated in Nrf2 knockout mice (Figure 3a and b) . At this time point, the difference in the number of neutrophils was statistically significant (Figure 3b) . The number of macrophages in the injured liver was determined by staining with an antibody against ER-MP23, a macrophage-specific lectin. 28 Infiltration of these cells peaked 48 h after CCl 4 injection in mice of both genotypes. Macrophages were still present 5 days after the insult. Although their number was slightly higher in the Nrf2 knockout mice, the difference was not statistically significant (data not shown). Mast cells could not be detected at any time point (data not shown).
To determine the reason for the persistence of inflammatory cells, we analyzed the expression of proinflammatory cytokines in injured liver of Nrf2 knockout mice using real-time RT-PCR. For this purpose, we used RNAs that were pooled from at least four mice per time point, and the experiment was repeated with a different set of RNAs from an independent experiment. At 24 h after injury, levels of IL-1a, TNF-a and IFN-g mRNAs were elevated in mice of both genotypes, but the increase was much higher in Nrf2-deficient mice (Figure 3c-e) . Expression levels of these cytokines, in particular of IFN-g, were still enhanced in Nrf2 knockout mice compared to controls at later stages after injury, although the difference was much less pronounced compared to the 24 h time point. Expression of IL-1b also increased after CCl 4 injection in mice of both genotypes, and this increase was slightly higher in Nrf2-deficient mice as determined by RNase protection assay (data not shown).
The Profibrotic Response is Enhanced and Prolonged in Nrf2 Knockout Mice After Acute CCl 4 -Induced Liver Damage
We next determined if the prolonged tissue injury and inflammation seen in CCl 4 -treated Nrf2 knockout mice is reflected by upregulation of genes that mediate the fibrotic response. Levels of TGF-b1 mRNA were induced 24 h after CCl 4 injection in mice of both genotypes (Figure 4 ). In addition, expression of the genes encoding Coll-Ia1 and TIMP-1 was induced 24 h after CCl 4 treatment, independent of the genotype (Figure 4 ). The expression of these genes reflects the onset of tissue remodeling processes, which can lead to fibrosis. 29 Between 72 and 120 h after CCl 4 injection, expression of these genes strongly declined in the wild-type 
Nrf2 Protects from CCl 4 -Induced Chronic Liver Injury
The prolonged tissue damage, inflammation and profibrotic response that was observed in Nrf2 knockout mice after acute CCl 4 injury suggested that the mutant mice are also more prone to chronic liver damage. To address this question, mice Nrf2 in liver fibrosis W Xu et al were subjected to long-term CCl 4 treatment (0.2 mg/g BW every third day for 6 weeks), which is known to induce liver fibrosis. 17 Livers were removed 45 days after the initial injection. Interestingly, the liver weight/body weight ratio was significantly reduced in CCl 4 -treated knockout mice, but not in wild-type littermates or in mineral oil-treated mice of both genotypes (Figure 5a ). To determine if this correlates with enhanced liver fibrosis, the fibrotic area was morphometrically determined in Sirius-red-stained sections, where fibrotic tissue can be identified by the red color of the collagen (Figure 5b) . In oil-treated mice, fibrosis was not observed and only a small area around blood vessels was stained with Sirius red (Figure 5b ), similar as in nontreated mice (data not shown). Upon long-term CCl 4 treatment, the percentage of fibrotic area was significantly higher in Nrf2 knockout mice compared to control animals ( Figure 5c ). This result was confirmed by staining of the sections with Masson trichrome (data not shown, NZ7, *P ¼ 0.04, 1.82 ± 0.16% and 2.56±0.24%). Further, these findings correlated with more extended deposition of the extracellular matrix protein fibronectin in Nrf2 knockout mice (Figure 5d and e) . Expression of Coll-Ia1 and of TIMP-1 was also elevated in fibrotic livers of Nrf2-deficient mice compared to control as determined by real-time RT-PCR (Figure 5f and g). Consistent with the lack of histological abnormalities, upregulation of these genes was not observed in oil-treated mice (Figure 5f and g ).
Serum bilirubin levels were increased more than twofold in CCl 4 -treated Nrf2 knockout mice compared to wild-type control animals (NZ7, *P ¼ 0.018, data not shown), indicating a more severe defect in liver function.
Finally, histological grading performed by two independent investigators revealed more severe inflammation in Nrf2 knockout mice compared to control animals ( Figure 5h ). This finding correlated with increased expression of IL-1a, TNF-a and macrophage chemoattractant protein-1 in fibrotic liver of the knockout mice as determined by RNase protection assay or real-time RT-PCR (data not shown).
No relevant hepatic fibrosis or inflammation was observed in oil-treated animals of both genotypes (data not shown).
Taken together, these results demonstrate that the lack of Nrf2 aggravates the chronic liver injury and fibrosis that develops after long-term CCl 4 treatment. Figure 4 The profibrotic response is prolonged in Nrf2 knockout mice after acute CCl 4 -mediated liver injury. Expression of genes involved in tissue remodeling was analyzed in wild-type and Nrf2-deficient mice at different time points after CCl 4 injection using real-time RT-PCR. Two batches of RNA from independent experiments were used. Expression of these genes in wild-type and Nrf2 knockout mice 24 h after vehicle (oil) injection is shown for comparison. Amplification of cDNA obtained from 18 s rRNA was used for normalization. Each RNA sample was pooled from at least four animals. Bars represent mean ± s.e.m. Note that the values are not statistically significant, as only two batches of RNAs were used. However, each batch of RNA was obtained from pooled liver of at least four animals.
Nrf2 in liver fibrosis W Xu et al determined the expression of major Nrf2 target genes. Indeed, expression of GCLC and of NQO1, which are involved in the maintenance of the cellular redox balance, was reduced after acute and chronic liver injury (Figure 6a and b) . As ROS play a key role in acute CCl 4 -induced liver injury, 30 their reduced detoxification is likely to contribute to the more severe liver injury in Nrf2 knockout mice. In addition, expression of glutathione S-transferases, which are involved in the detoxification of CCl 4 and its metabolites, was upregulated within 24-48 h after injection of CCl 4 in wild-type mice, but to a much lesser extent in Nrf2-deficient mice. This effect was particularly pronounced for GST-Ya and to a lesser extent for GST-p (Figure 6a and b) .
Microarray analysis of RNA from noninjured, nontreated liver 10 and from livers treated with Nrf2 activators 31-33 of wild-type and Nrf2 knockout mice revealed Ces 1-3, Aox 1 and UDP-glucuronosyl transferase 2 family, polypeptide (ugt2) B35 and B36 as potential targets of Nrf2. These enzymes are involved in the detoxification of CCl 4 and its metabolites. 3 To verify some of these findings, we analyzed the expression of the ces1 and aox1 genes by semiquantitative RT-PCR. A slight reduction of ces1 and aox1 gene expression was observed in resting livers of Nrf2 knockout mice. Most importantly, expression of these genes was much lower in livers of CCl 4 -treated Nrf2 knockout mice compared to control animals (Figure 6c ). These results suggest that enhanced expression of various detoxifying genes in the injured liver reduces CCl 4 -induced cytotoxicity and that this effect is at least partially mediated by Nrf2.
DISCUSSION
The Nrf2 transcription factor was previously shown to protect from ROS-and toxin-induced tissue damage through its capacity to induce the expression of genes encoding ROS-and drug-detoxifying enzymes. 7 The results presented in this study extend these findings to the protection from CCl 4 -induced liver injury. Most importantly, we provide first evidence for a potent role of Nrf2 in the protection from liver fibrosis/cirrhosis and we identified some of the responsible target genes.
CCl 4 treatment is a widely used model to induce liver cell death and, depending on dose and persistence of the insult, liver fibrosis. 17 The mechanism by which CCl 4 exerts its toxicity is well characterized. Members of the cytochrome P450 oxidase family metabolize CCl 4 to the trichloromethylfree radical (CCl 3 K ). 34 This highly unstable and reactive molecule can directly haloalkylate nucleic acids, proteins and lipids and thereby disturb cell homeostasis. In addition, CCl 3 K can react with oxygen to form trichloromethyl peroxy radicals (CCl 3 OO K ), which subsequently cause lipid peroxidation. This in turn leads to membrane dysfunction and to accumulation of reactive aldehydes, such as 4-hydroxynonenal. 3 It has been speculated that detoxification and excretion of reactive aldehydes, haloalkylated macromolecules and other by-products of CCl 4 metabolism is dependent on phase II detoxifying enzymes such as GSTs, UDP-glucuronosyl transferases, Aox, Ces and proteins involved in glutathione biosynthesis. 35, 36 Here, we demonstrate that lack of Nrf2 results in aggravated liver damage after a single, nonlethal dose of CCl 4 . The initial injury was comparable between wild-type and knockout animals, but persisted longer in the latter due to an impaired repair capacity (Figure 1) . Expression of detoxifying enzymes such as GST-Ya, GST-p, GCLC, NQO1, Ces1 and Aox1 peaked 24 h after injection in wild-type animals, whereas the induction of these enzymes was reduced or completely abrogated in Nrf2-deficient mice (Figure 6a and c) . This is likely to result in accumulation and prolonged presence of toxic products of CCl 4 metabolism, which in turn inhibit an efficient repair process (Figure 2 ), perpetuate necrotic cell death and thereby cause prolonged inflammation (Figure 3) . The observed phenotype is in accordance with previous studies using acetaminophen as toxin.
11,12
Interestingly, we observed a prolonged expression of TIMP-1, TGF-b1 and Coll-Ia1 after a single dose of CCl 4 . Aberrant expression of these genes in the liver indicates the onset of liver fibrosis. 29 In addition, oxidative stress, caused by impaired defense against xenobiotics, can lead to the activation of HSCs and thereby to fibrosis. 4 We therefore further investigated the role of Nrf2 in chemically induced liver fibrosis. Indeed, livers from Nrf2 knockout mice were more susceptible to CCl 4 -induced fibrosis ( Figure 5 ). Similar to the situation after acute liver injury, reduced basal and inducible expression of Nrf2 target genes was observed, which most likely contributes to the observed pathogenesis (Figure 6b ). Thus, it seems likely that reduced detoxification and accumulation of CCl 4 metabolites leads to prolonged hepatocyte damage and inflammation, which in turn promotes fibrosis. To further characterize the phenotype, we applied a second model of experimental fibrosis, bile duct ligation (BDL). Some Nrf2 knockout animals also showed high susceptibility to BDL, but with a high degree of variability (data not shown). A likely explanation is provided by the studies of Aleksunes et al. 16 They showed that despite the induction of Nrf2 target genes by BDL, Nrf2 knockout mice are not suffering from aggravated liver damage, most likely due to a reduced bile production in these animals.
In summary, our results provide a causal link between the reduced expression of cytoprotective proteins and the initiation and progression of liver fibrosis. This is of high clinical importance, as abuse of alcohol or other drugs induces similar damage to the liver as seen in the experimental model of CCl 4 intoxication. 37 In particular, the detoxification of these drugs also requires the action of detoxifying enzymes, which are controlled by Nrf2. Therefore, genetic 38 or pharmacological activation of Nrf2 by sulforaphane 32 or butylated hydroxyanisole 33 may represent a useful strategy to prevent liver damage after various toxic insults. This hypothesis is supported by the beneficial effect of curcumin on CCl 4 -mediated liver fibrosis, 30 which may Nrf2 in liver fibrosis W Xu et al be at least in part mediated through activation of Nrf2 by this polyphenolic antioxidant. 39 In the future, some of these agents may potentially be used as supportive medication to reduce or even prevent toxin-induced liver fibrosis and possibly also to slow down its progression. Future studies will experimentally address this possibility. 
